Altered dopamine receptor and dopamine transporter binding and tyrosine hydroxylase mRNA expression following perinatal NMDA receptor blockade

Neurochemical Research

Volumn 33, Issue 7, 2008, Pages 1224-1231

  Du Bois, Teresa Marie ^a,b   Hsu, Ching Wen ^a,b   Li, Yulin ^b   Tan, Yean Yeow ^a,b   Deng, Chao ^a,b   Huang, Xu Feng ^a,b  

^a SCHIZOPHRENIA RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

Brain development; Dopaminergic system; NMDA receptor; Phencyclidine

Indexed keywords

DOPAMINE RECEPTOR; DOPAMINE TRANSPORTER; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHENCYCLIDINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; NONHUMAN; NUCLEUS ACCUMBENS; PERINATAL PERIOD; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; VENTRAL TEGMENTUM;

ANIMALS; AUTORADIOGRAPHY; BRAIN CHEMISTRY; COCAINE; DOPAMINE ANTAGONISTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; IN SITU HYBRIDIZATION; PHENCYCLIDINE; PREGNANCY; RACLOPRIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RECEPTORS, N-METHYL-D-ASPARTATE; RNA, MESSENGER; TYROSINE 3-MONOOXYGENASE;

RATTUS;

EID: 44549087819     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-007-9571-y     Document Type: Article

References (55)

1. Ikonomidou C, Bosch F, Miksa M et al (1999) Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283:70-74
2. Fredriksson A, Archer T, Alm H et al (2004) Neurofunctional deficits and potentiated apoptosis by neonatal NMDA antagonist administration. Behav Brain Res 153:367-376
3. Hansen HH, Briem T, Dzietko M et al (2004) Mechanisms leading to disseminated apoptosis following NMDA receptor blockade in the developing rat brain. Neurobiol Dis 16:440-453
4. Harris LW, Sharp T, Gartlon J et al (2003) Long-term behavioural, molecular and morphological effects of neonatal NMDA receptor antagonism. Eur J Neurosci 18:1706-1710
5. Hwang J-Y, Kim Y-H, Ahn Y-H et al (1999) N-methyl-aspartate receptor blockade induces neuronal apoptosis in cortical culture. Exp Neurol 159:124-130
6. Monti B, Contestabile A (2000) Blockade of the NMDA receptor increases developmental apoptotic elimination of granule neurons and activates caspases in the rat cerebellum. Eur J Neurosci 12:3117-3123
7. Wang C, McInnis J, Ross-Sanchez M et al (2001) Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia. Neuroscience 107:535-550
8. Olney JW, Labruyere J, Wang G et al (1991) NMDA antagonist neurotoxicity: mechanism and prevention. Science 254:1515-1518
9. Dobbing J, Sands J (1979) Comparative aspects of the brain growth spurt. Early Hum Dev 3:79-83
10. Brooks WJ, Weeks AC, Leboutillier JC et al (1997) Altered NMDA sensitivity and learning following chronic developmental NMDA antagonism. Physiol Behav 62:955-962
11. Latysheva NV, Rayevsky KS (2003) Chronic neonatal N-methyl-aspartate receptor blockade induces learning deficits and transient hypoactivity in young rats. Prog Neuropsychopharmacol Biol Psychiatry 27:787-794
12. Sircar R (2003) Postnatal phencyclidine-induced deficit in adult water maze performance is associated with N-methyl-aspartate receptor upregulation. Int J Dev Neurosci 21:159-167
13. Wiley JL, Buhler KG, Lavecchia KL et al (2003) Pharmacological challenge reveals long-term effects of perinatal phencyclidine on delayed spatial alternation in rats. Prog Neuropsychopharmacol Biol Psychiatry 27:867-873
14. Facchinetti F, Ciani E, Dall'Olio R et al (1993) Structural, neurochemical and behavioural consequences of neonatal blockade of NMDA receptor through chronic treatment with CGP 39551 or MK-801. Dev Brain Res 74:219-224
15. Wang C, McInnis J, West JB et al (2003) Blockade of phencyclidine-induced cortical apoptosis and deficits in prepulse inhibition by M40403, a superoxide dismutase mimetic. J Pharmacol Exp Ther 304:266-271
16. Boksa P, El-Khodor BF (2003) Birth insult interacts with stress at adulthood to alter dopaminergic function in animal models: possible implications for schizophrenia and other disorders. Neurosci Biobehav Rev 27:91-101
17. Davis KL, Kahn RS, Ko G et al (1991) Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 148:1474-1486
18. Lacroix L, Spinelli S, White W et al (2000) The effects of ibotenic acid lesions of the medial and lateral prefrontal cortex on latent inhibition, prepulse inhibition and amphetamine-induced hyperlocomotion. Neuroscience 97:459-468
19. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic Press Inc., London
20. Siemiatkowski M, Maciejak P, Wislowska A et al (2004) Neophobia and cortical and subcortical binding of the dopamine D2 receptor antagonist [3H]-raclopride. Life Sci 76:753-761
21. Isovich E, Mijnster MJ, Flugge G et al (2000) Chronic psychosocial stress reduces the density of dopamine transporters. Eur J Neurosci 12:1071-1078
22. Hu Z, Cooper M, Crockett DP et al (2004) Differentiation of the midbrain dopaminergic pathways during mouse development. J Comp Neurol 476:301-311
23. Tarazi FI, Florijn WJ, Creese I (1996) Regulation of ionotropic glutamate receptors following subchronic and chronic treatment with typical and atypical antipsychotics. Psychopharmacology 128:371-379
24. Teicher MH, Andersen SL, Hostetter JC (1995) Evidence for dopamine-receptor pruning between adolescence and adulthood in striatum but not nucleus-accumbens. Brain Res Dev Brain Res 89:167-172
25. Andersen SL, Rutstein M, Benzo JM et al (1997) Sex differences in dopamine receptor overproduction and elimination. Neuroreport 8:1495-1498
26. Gelbard HA, Teicher MH, Faedda JG et al (1989) Postnatal development of dopamine D1 and D2 receptor sites in rat striatum. Brain Res 49:123-130
27. Deng C, Eftimovska J, Zavitsanou K et al. (2007) Phencyclidine induces apoptosis in the brain of neonatal but not adolescent and adult rats. 7th IBRO World Congress of Neuroscience, Melbourne, Australia
28. Changeux JP, Danchin A (1976) Selective stabilisation of developing synapses as a mechanism for the specification of neuronal networks. Nature 264:705-712
29. Pearce IA, Cambray-Deakin MA, Burgoyne RD (1987) Glutamate acting on NMDA receptors stimulates neurite outgrowth from cerebellar granule cells. FEBS Lett 223:143-147
30. Sircar R, Soliman KFA (2003) Effects of postnatal PCP treatment on locomotor behavior and striatal D2 receptor. Pharmacol Biochem Behav 74:943-952
31. Gorter JA, Botterblom MH, Feenstra MG et al (1992) Chronic neonatal NMDA receptor blockade with MK-801 alters monoamine metabolism in the adult rat. Neurosci Lett 137:97-100
32. Dall'Olio R, Facchinetti F, Contestabile A et al (1994) Chronic neonatal blockade of N-methyl-D-Aspartate receptor by CGP 39551 increases dopaminergic function in adult rat. Neuroscience 63:451-455
33. Ciliax BJ, Drash GW, Staley JK et al (1999) Immunocytochemical localization of the dopamine transporter in human brain. J Comp Neurol 409:38-56
34. Coulter CL, Happe HK, Murrin LC (1997) Dopamine transporter development in postnatal rat striatum, an autoradiographic study with H-3 WIN 35,428. Brain Res Dev Brain Res 104:55-62
35. González-Hernández T, Barroso-Chinea P, de la Cruz Muros I et al (2004) Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons. J Comp Neurol 479:198-215
36. Gulley JM, Zahniser NR (2003) Rapid regulation of dopamine transporter function by substrates, blockers and presynaptic receptor ligands. Eur J Pharmacol 479:139-152
37. Jones SR, Gainetdinov RR, Jaber M et al (1998) Profound neuronal plasticity in response to inactivation of the dopamine transporter. PNAS 95:4029-4034
38. Jones SR, Gainetdinov RR, Wightman RM et al (1998) Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J Neurosci 18:1979-1986
39. Jones SR, Gainetdinov RR, Hu X-T et al (1999) Loss of autoreceptor functions in mice lacking the dopamine transporter. Nat Neurosci 2:649-655
40. Joyce J, Woolsey C, Ryoo H et al (2004) Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor. BMC Biol 2:22
41. --dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol Ther 92:21-55
42. 3H]mazindol binding sites in rat striatum by dopaminergic agents. Eur J Pharmacol 250:261-266
43. Gordon I, Weizman R, Rehavi M (1996) Modulatory effect of agents active in the presynaptic dopaminergic system on the striatal dopamine transporter. Eur J Pharmacol 298:27-30
44. Adams B, Moghaddam B (1998) Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. J Neurosci 18:5545-5554
45. du Bois TM, Huang XF, Deng C (2007) Perinatal administration of PCP alters adult behaviour in female Sprague-Dawley rats. Behav Brain Res. doi: 10.1016/j.bbr.2007.11.017
46. Seeman P, Weinshenker D, Quirion R et al (2005) Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis. PNAS 102:3513-3518
47. Hietala J, Syvalahti E, Vilkman H et al (1999) Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia. Schizophr Res 35:41-50
48. Hietala J, Syvalahti E, Vuorio K et al (1995) Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients. Lancet 346:1130
49. Lindstrom LH, Gefvert O, Hagberg G et al (1999) Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by -([beta]-11C) DOPA and PET. Biol Psychiatry 46:681-688
50. Reith J, Benkelfat C, Sherwin A et al (1994) Elevated dopa decarboxylase activity in living brain of patients with psychosis. PNAS 91:11651-11654
51. Abi-Dargham A, Rodenhiser J, Printz D et al (2000) Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. PNAS 97:8104-8109
52. Abi-Dargham A, Gil R, Krystal J et al (1998) Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am J Psychiatry 155:761-767
53. Breier A, Su TP, Saunders R et al (1997) Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. PNAS 94:2569-2574
54. Laruelle M, Abi-Dargham A, van Dyck CH et al (1996) Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. PNAS 93:9235-9240
55. Silvestri S, Seeman MV, Negrete JC et al (2000) Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study. Psychopharmacology 152:174-180